About Haut
Haut is a company based in Tallinn (Estonia) founded in 2017. Haut has raised $2.15 million across 1 funding round from investors including LongeVC. Haut operates in a competitive market with competitors including Nosto, Castle Biosciences, DermTech, PathologyWatch and Monetate, among others.
- Headquarter Tallinn, Estonia
-
Sectors
TechnologyHealthcare Retail
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hautai Oü
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.15 M (USD)
in 1 rounds
-
Latest Funding Round
$2.15 M (USD), Seed
Nov 15, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Haut
Unlock access to complete
Unlock access to complete
Funding Insights of Haut
Haut has successfully raised a total of $2.15M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.15 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Haut
Haut has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LongeVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
LongeVC is focused on venture capital investments in biotech.
|
Locked | Locked | Locked |
Investor details for Haut
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haut
Investment portfolio details for Haut
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haut
Detailed financials for Haut
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haut Comparisons
Peer comparison for Haut
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haut
Haut operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nosto, Castle Biosciences, DermTech, PathologyWatch and Monetate, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personalized product recommendations are delivered via SaaS to online retailers.
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Clinical workflow software and services are provided for pathology professionals.
|
|
| Locked | Locked | Locked |
Personalized solutions for businesses are delivered via an end-to-end platform.
|
|
| Locked | Locked | Locked |
Prognostic tests for early-stage melanoma detection are developed.
|
Detailed competitors of Haut
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haut
Complete news archive for Haut
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haut
Haut was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Haut is headquartered in Tallinn, Estonia.
Haut is a funded company, having raised a total of $2.15M across 1 funding round to date.
Haut was founded in 2017 in Tallinn, Estonia, as a provider of SaaS-based tools tailored to skincare businesses. Operations focus on computer vision and machine learning algorithms to analyze skin conditions. Personalized treatment plans are generated for users based on these analyses. The company serves the beauty tech sector, enabling businesses to offer data-driven skincare services across digital platforms.
Haut has 1 investor. Key investors include LongeVC.